1. (2006) Access to therapeutic products: the regulatory process in Canada (Health Products and Food Branch, Health Canada, Ottawa) Available: https://publications.gc.ca/collections/collection_2007/hc-sc/H164-9-2006E.pdf . accessed 2022 Mar. 4.
2. (2019) A prescription for Canada: achieving pharmacare for all (Health Canada, Ottawa).
3. About CADTH (Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa) updated 2022 Apr. 12. Available: https://www.cadth.ca/about-cadth . accessed 2022 Mar. 4.
4. (2021) Médicaments en attente d’un avis de conformité (Institut national d’excellence en santé et en services sociaux, Québec) Available: https://www.inesss.qc.ca/index.php?id=818 . accessed 2022 Mar. 4.
5. Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans;Salek;Front Pharmacol,2019